SEGMENT INFORMATION

9 Months Ended

Apr. 30, 2012

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

The Company’s reportable segments, which are also its operating segments, consist of the Company’s Life Sciences and Industrial businesses.

The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes, for the three and nine months ended April 30, 2012 and April 30, 2011. The Life Sciences and Industrial results have been restated to reflect the change in allocation of certain shared expenses on a continuing operations basis.

	Three Months Ended				Nine Months Ended
	Apr 30, 2012		Apr 30, 2011		Apr 30, 2012		Apr 30, 2011
SALES:
Life Sciences	$	317,969	$	312,691	$	918,954	$	852,463
Industrial	340,007		341,101		1,030,331		946,016
Total	$	657,976	$	653,792	$	1,949,285	$	1,798,479
SEGMENT PROFIT:
Life Sciences	$	75,386	$	78,885	$	233,191	$	213,667
Industrial	39,431		47,200		131,195		134,256
Total segment profit	114,817		126,085		364,386		347,923
Corporate Services Group	16,397		16,454		49,776		45,755
Operating profit	98,420		109,631		314,610		302,168
ROTC	2,861		7,723		31,001		13,921
Interest expense, net	6,351		6,068		17,682		19,176
Earnings from continuing operations before income taxes	$	89,208	$	95,840	$	265,927	$	269,071